Trial intelligence / Profile preview

BCG Vaccination for COVID-19 in Healthcare Workers

NCT04379336Phase 3Completed

Sponsor
TASK Foundation
Start
May 2020
Primary completion
Jan 2022
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of bcg vaccine in coronavirus disease 2019 (COVID-19), sponsored by TASK Foundation. Started May 2020; status: completed.

02

Drugs

bcg vaccine
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04379336.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04379336.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call